Sphera Funds Management LTD. trimmed its position in shares of Kadmon Holdings Inc (NYSE:KDMN) by 4.0% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 1,490,000 shares of the company’s stock after selling 62,846 shares during the quarter. Sphera Funds Management LTD.’s holdings in Kadmon were worth $4,977,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in KDMN. Vivo Capital LLC boosted its holdings in Kadmon by 213.6% in the second quarter. Vivo Capital LLC now owns 10,454,545 shares of the company’s stock valued at $68,919,000 after purchasing an additional 7,121,212 shares in the last quarter. Acuta Capital Partners LLC boosted its holdings in Kadmon by 52.3% in the second quarter. Acuta Capital Partners LLC now owns 9,060,014 shares of the company’s stock valued at $36,149,000 after purchasing an additional 3,110,014 shares in the last quarter. BlackRock Inc. boosted its holdings in Kadmon by 42.1% in the third quarter. BlackRock Inc. now owns 6,768,569 shares of the company’s stock valued at $22,606,000 after purchasing an additional 2,005,133 shares in the last quarter. VHCP Management III LLC acquired a new position in Kadmon in the third quarter valued at approximately $7,978,000. Finally, Marshall Wace LLP boosted its holdings in Kadmon by 63.6% in the second quarter. Marshall Wace LLP now owns 1,704,894 shares of the company’s stock valued at $6,803,000 after purchasing an additional 662,773 shares in the last quarter. Hedge funds and other institutional investors own 71.17% of the company’s stock.
A number of brokerages recently issued reports on KDMN. Zacks Investment Research raised Kadmon from a “hold” rating to a “buy” rating and set a $2.75 price target for the company in a report on Thursday, November 15th. HC Wainwright reaffirmed a “buy” rating and issued a $25.00 price target on shares of Kadmon in a report on Monday, November 12th. ValuEngine raised Kadmon from a “hold” rating to a “buy” rating in a report on Wednesday, November 7th. Finally, WBB Securities raised Kadmon from a “sell” rating to a “hold” rating and set a $2.90 price target for the company in a report on Wednesday, October 17th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Kadmon has a consensus rating of “Buy” and an average target price of $11.13.
TRADEMARK VIOLATION WARNING: “Sphera Funds Management LTD. Sells 62,846 Shares of Kadmon Holdings Inc (KDMN)” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.chaffeybreeze.com/2018/12/08/sphera-funds-management-ltd-sells-62846-shares-of-kadmon-holdings-inc-kdmn.html.
Kadmon Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas, including tetrabenazine for the treatment of chorea associated with Huntington's disease.
Featured Story: Stop Order
Want to see what other hedge funds are holding KDMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kadmon Holdings Inc (NYSE:KDMN).
Receive News & Ratings for Kadmon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon and related companies with MarketBeat.com's FREE daily email newsletter.